HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systematic discovery of mutation-directed neo-protein-protein interactions in cancer.

Abstract
Comprehensive sequencing of patient tumors reveals genomic mutations across tumor types that enable tumorigenesis and progression. A subset of oncogenic driver mutations results in neomorphic activity where the mutant protein mediates functions not engaged by the parental molecule. Here, we identify prevalent variant-enabled neomorph-protein-protein interactions (neoPPI) with a quantitative high-throughput differential screening (qHT-dS) platform. The coupling of highly sensitive BRET biosensors with miniaturized coexpression in an ultra-HTS format allows large-scale monitoring of the interactions of wild-type and mutant variant counterparts with a library of cancer-associated proteins in live cells. The screening of 17,792 interactions with 2,172,864 data points revealed a landscape of gain of interactions encompassing both oncogenic and tumor suppressor mutations. For example, the recurrent BRAF V600E lesion mediates KEAP1 neoPPI, rewiring a BRAFV600E/KEAP1 signaling axis and creating collateral vulnerability to NQO1 substrates, offering a combination therapeutic strategy. Thus, cancer genomic alterations can create neo-interactions, informing variant-directed therapeutic approaches for precision medicine.
AuthorsXiulei Mo, Qiankun Niu, Andrey A Ivanov, Yiu Huen Tsang, Cong Tang, Changfa Shu, Qianjin Li, Kun Qian, Alafate Wahafu, Sean P Doyle, Danielle Cicka, Xuan Yang, Dacheng Fan, Matthew A Reyna, Lee A D Cooper, Carlos S Moreno, Wei Zhou, Taofeek K Owonikoko, Sagar Lonial, Fadlo R Khuri, Yuhong Du, Suresh S Ramalingam, Gordon B Mills, Haian Fu
JournalCell (Cell) Vol. 185 Issue 11 Pg. 1974-1985.e12 (05 26 2022) ISSN: 1097-4172 [Electronic] United States
PMID35512704 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2022 Elsevier Inc. All rights reserved.
Chemical References
  • Kelch-Like ECH-Associated Protein 1
  • NF-E2-Related Factor 2
  • Proto-Oncogene Proteins B-raf
Topics
  • Carcinogenesis
  • Humans
  • Kelch-Like ECH-Associated Protein 1 (genetics, metabolism)
  • Mutation
  • NF-E2-Related Factor 2 (metabolism)
  • Neoplasms (genetics)
  • Proto-Oncogene Proteins B-raf (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: